Literature DB >> 10436370

Beneficial effects of hydrocortisone in a model of experimental acute pancreatitis.

M O Osman1, N O Jacobsen, J U Kristensen, C G Larsen, S L Jensen.   

Abstract

BACKGROUND: Proinflammatory cytokines like TNF-alpha and IL-8 have been thought to play a pivotal role in the propagation of severe acute pancreatitis (AP) and the development of its systemic complications, particularly acute lung injury.
OBJECTIVE: To investigate the effects of pretreatment with hydrocortisone on the production of cytokines and the occurrence of acute lung injury in rabbits with AP.
METHODS: AP was induced in 17 rabbits by infusion of 5% chenodeoxycholic acid into the pancreatic duct, followed by ductal ligation. The rabbits were allocated to pretreatment with subcutaneous and intravenous hydrocortisone (25 mg/kg, respectively; n = 7) or 0.9% saline (n = 10) 30 min before induction of AP. Rabbits were observed for 12 h. Serum amylase, lipase, TNF-alpha, IL-8, glucose, calcium and leukocyte count were measured every 3 h. At the end of the experimental period, ascitic fluid was collected and tissue specimens from the pancreas, lungs and kidney were obtained.
RESULTS: Hydrocortisone pretreatment improved survival from 40 to 100%. Serum TNF-alpha and IL-8 were lower in the hydrocortisone group than in the control group at 6 h (p = 0.006 and p < 0.001, respectively). Hydrocortisone abolished leukopenia (p < 0. 001), hyperamylasemia (p = 0.05), the occurrence of acute lung injury and reduced the volume of ascites.
CONCLUSIONS: Our findings suggest a role for TNF-alpha and IL-8 in mediating the progress of AP from a local disease into a systemic illness. Hydrocortisone should be tested experimentally after the induction of AP and clinically as a prophylactic measure to avoid severe AP induced by endoscopic retrograde cholangiopancreaticography.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10436370     DOI: 10.1159/000018730

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  7 in total

1.  Efficacy of glucocorticoids in rodents of severe acute pancreatitis: a meta-analysis.

Authors:  Min Yu; Zhen Yang; Yin Zhu; Nonghua Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Hydrocortisone treatment of early SIRS in acute experimental pancreatitis.

Authors:  B Gloor; W Uhl; O Tcholakov; A Roggo; C A Muller; M Worni; M W Büchler
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

3.  Dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins.

Authors:  Emad Kandil; Yin-Yao Lin; Martin-H Bluth; Hong Zhang; Gabriel Levi; Michael-E Zenilman
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

4.  Relative adrenal insufficiency in patients with severe acute pancreatitis.

Authors:  Jan J De Waele; Eric A J Hoste; Didier Baert; Koen Hendrickx; Dirk Rijckaert; Patrick Thibo; Philippe Van Biervliet; Stijn I Blot; Francis Colardyn
Journal:  Intensive Care Med       Date:  2007-06-16       Impact factor: 17.440

Review 5.  Pharmacologic therapy for acute pancreatitis.

Authors:  Swetha Kambhampati; Walter Park; Aida Habtezion
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Dexamethasone and dextran 40 treatment of 32 patients with severe acute pancreatitis.

Authors:  Zi-Fa Wang; Chang Liu; Yi Lu; Rui Dong; Jun Xu; Liang Yu; Ying-Min Yao; Qing-Guang Liu; Cheng-En Pan
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

7.  Protective effect of phosphatidylcholine on lipopolysaccharide-induced acute inflammation in multiple organ injury.

Authors:  Yoon Yang Jung; Yunsung Nam; Yong Seol Park; Ho Sung Lee; Soon Auck Hong; Beom Keun Kim; Eon Sub Park; Yoon Hee Chung; Ji Hoon Jeong
Journal:  Korean J Physiol Pharmacol       Date:  2013-06-11       Impact factor: 2.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.